Catalysis of salicylaldehydes and two different C-H acids with electricity:: First example of an efficient multicomponent approach to the design of functionalized medicinally privileged 2-Amino-4H-Chromene scaffold

被引:123
作者
Elinson, Michail N. [1 ]
Dorofeev, Alexander S. [1 ]
Miloserdov, Fedor M. [1 ]
Ilovalsky, Alexey I. [1 ]
Feducovich, Sergey K. [1 ]
Belyakov, Pavel A. [1 ]
Nikishin, Gennady I. [1 ]
机构
[1] ND Zelinskii Inst Organ Chem, Moscow 119991, Russia
关键词
C-H acids; chromenes; electrocatalysis; multicomponent reactions; salicylaldehydes;
D O I
10.1002/adsc.200700493
中图分类号
O69 [应用化学];
学科分类号
081704 [应用化学];
摘要
Electrochemically induced multicomponent transformation of salicylaldehydes and two different C-H acids in alcohols in an undivided cell in the presence of sodium bromide as an electrolyte results in the efficient and selective formation of diversely functionalized, medicinally privileged 2-amino-4H-chromene scaffolds in 65-86% yields. The developed electrocatalytic system affords the distinction between two C-H acids according to their reactivity, and offers an efficient approach to the 2-amino-4H-chromene scaffold with a predefined arrangement of desired substituents. The electrocatalytic multicomponent reaction smoothly proceeds with salicylaldehydes bearing both electron-donating and electron-withdrawing groups. Thus, fifteen previously inaccessible, close structural analogues of the tumor antagonists HA14-1 and MX58151 have been synthesized. The electrocatalytic process was found to be advantageous in terms of selectivity and yields compared to classic chemical base catalysis, and includes a remarkable mechanistic feature that is promising for the further development of 2-amino-4H-chromene chemistry. The application of this convenient electrocatalytic multicomponent method to the formation of medicinally relevant 2-amino-4H-chromenes is also beneficial from the viewpoint of diversity-oriented large-scale processes and represents a novel, facile and environmentally benign synthetic concept for multicomponent reaction strategy.
引用
收藏
页码:591 / 601
页数:11
相关论文
共 57 条
[1]
Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2) [J].
Anderson, DR ;
Hegde, S ;
Reinhard, E ;
Gomez, L ;
Vernier, WF ;
Lee, L ;
Liu, S ;
Sambandam, A ;
Snider, PA ;
Masih, L .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) :1587-1590
[2]
Andreani L.L., 1960, BOLL CHIM FARM, V99, P583
[3]
The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[4]
Bienaymé H, 2000, CHEM-EUR J, V6, P3321, DOI 10.1002/1521-3765(20000915)6:18<3321::AID-CHEM3321>3.0.CO
[5]
2-A
[6]
FLAVONOIDS OF BALSAMORHIZA AND WYETHIA [J].
BOHM, BA ;
CHOY, JB ;
LEE, AYM .
PHYTOCHEMISTRY, 1989, 28 (02) :501-503
[7]
SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF 2-OXO-(2H) 1-BENZOPYRAN-3-CARBOXAMIDE DERIVATIVES [J].
BONSIGNORE, L ;
LOY, G ;
SECCI, D ;
CALIGNANO, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1993, 28 (06) :517-520
[8]
The recent impact of solid-phase synthesis on medicinally relevant benzoannelated nitrogen heterocycles [J].
Bräse, S ;
Gil, C ;
Knepper, K .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (08) :2415-2437
[9]
Potassium exchanged layered zirconium phosphate as catalyst in the preparation of 4H-chromenes [J].
Curini, M ;
Epifano, F ;
Chimichi, S ;
Montanari, F ;
Nocchetti, M ;
Rosati, O .
TETRAHEDRON LETTERS, 2005, 46 (20) :3497-3499
[10]
Privileged structures: Applications in drug discovery [J].
DeSimone, RW ;
Currie, KS ;
Mitchell, SA ;
Darrow, JW ;
Pippin, DA .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2004, 7 (05) :473-493